Orthobiologics

TheraCell announced pending issuance of a U.S. patent for DBF™ demineralized bone fiber, part of AlloSource’s AlloFuse® Cortical Fibers and AlloFuse® Fiber...

Results from a study of AMNIOX Medical’s proprietary cryopreserved Amniotic Membrane as an adjunct to lumbar discectomy indicate improved outcomes in disability...

Histogenics has now enrolled ~3/4 of 245 patients required to complete enrollment of its ongoing NeoCart® Phase III clinical trial....

CollPlant received CE Mark approval for Vergenix™STR soft tissue repair matrix for the treatment of tendinopathy. EU launch is anticipated...

Lattice Biologics launched AmnioVisc™, a minimally-processed amniotic fluid supplement for the treatment of osteoarthritis pain in all joints....

Spineology received FDA 510(k) clearance for use of allograft bone with Rampart™ Interbody Fusion Devices....

Bone Therapeutics reported positive efficacy data from its Phase IIA trial of ALLOB® in spinal fusion....

Stryker Spine launched LITe® BIO, a hand-held bone graft material delivery device....

Study results support the biocompatibility of Rotation Medical’s collagen-based bioinductive implant and its ability to promote new connective tissue with...

Regentis Biomaterials received FDA Investigational Device Exemption approval to initiate a pivotal Phase III clinical study of its GelrinC procedure to...